Neurology® Podcast

Dr. Tesha Monteith talks with Dr. Peter Goadsby about advances in headache science and classification.  Read the fourth edition of the International Classification of Headache Disorders. Disclosures can be found at Neurology.org. 

Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis. Read the related article on Tolebrutinib versus Teriflunomide in The New England Journal of Medicine. Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in The New England Journal of Medicine. Disclosures can be found at Neurology.org. 

Dr. Jeff Ratliff talks with Dr. Harry W. Sutherland about diversity in teaching methods, the balance between clinical responsibilities and educational opportunities, and innovative models like the academic half day. Read the related article in Neurology® Education. Disclosures can be found at Neurology.org. 

Dr. Jessica Ailani talks with Dr. Richard B. Lipton about the significance of recognizing prodromal symptoms, the findings from the PRODROME trial, and the implications for clinical practice.  Read the related article with Neurology® Clinical Practice. Disclosures can be found at Neurology.org.   

Prof. Jon Stone talks with Dr. Laura Strom and Meagan Watson about changes in total emergency department and inpatient visits and costs before and after referral to a specialized, comprehensive functional seizure treatment clinic. Read the related article with Neurology® Clinical Practice. Disclosures can be found at Neurology.org.   

Neurology® Open Access has officially launched.  In this episode, Dr. Jeff Ratliff and NOA Editor, Dr. Amy C. Kunchok share insights about Neurology® Open Access (NOA). Read more about Neurology® Open Access in this editorial, and visit the Neurology® Open Access website.   Disclosures can be found at Neurology.org.

Dr. Jeff Ratliff talks with Dr. Mehari Gebreyohanns, the recipient of the 2025 Ted Burns Humanism in Neurology Award, about his journey into stroke care, the BORNE initiative, and the challenges faced in global neurology. Disclosures can be found at Neurology.org.

The April 2025 replay showcases five compelling physician-as-patient stories. The episode begins with Dr. Franzi Herpich sharing her personal experience of suffering a stroke. It then transitions into a two-part series on arteriovenous malformation, featuring stories from Dr. Joe Sirven and Dr. Amy Hessler. The fourth episode highlights Dr. Eric Seachrist's journey with multiple sclerosis. In the final episode, Dr. Andrea Lendaris discusses her experience with Usher syndrome type 2A and her ongoing battle with acute and chronic health challenges.  Podcast links: Physician as Patient - Stroke  Physicians as Patients Series - Arteriovenous Malformation - Part 1 Physicians as Patients Series - Arteriovenous Malformation - Part 2  Physician as Patient Series - Multiple Sclerosis  Physicians as Patients Series - Inclusivity of Physicians with Disabilities  April 2022 Recall: Physician as Patient  Disclosures can be found at Neurology.org.

Dr. Jennifer Morganroth, a Neuromuscular and EMG fellow at Columbia, discusses the dramatic increase in thymectomy procedures for myasthenia gravis since the groundbreaking MGTX trial in 2016. She highlights significant disparities in access to these surgeries, especially among African-American patients and women. The conversation also delves into the impact of hospital characteristics and patient communication on treatment availability. Moreover, they explore the shift towards minimally invasive surgical techniques and the implications of new non-surgical treatments for future practices.

Dr. Stefan Pulst, Chair of Neurology and Human Genetics at the University of Utah, delves into a decade of transformative changes in neurology genetics. He discusses the impact of the dedicated journal launched in 2015, which has helped connect genetic variants to rare diseases. The conversation highlights significant advances in genetic testing and how these developments are shaping personalized treatments. Lastly, he touches on the challenges of developing genetic therapies and the importance of collaboration and mentorship within the growing neurogenetics community.